KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Current Assets (2016 - 2025)

Eli Lilly's Current Assets history spans 17 years, with the latest figure at $55.6 billion for Q4 2025.

  • For Q4 2025, Current Assets rose 69.91% year-over-year to $55.6 billion; the TTM value through Dec 2025 reached $55.6 billion, up 69.91%, while the annual FY2025 figure was $55.6 billion, 69.91% up from the prior year.
  • Current Assets reached $55.6 billion in Q4 2025 per LLY's latest filing, down from $62.1 billion in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $62.1 billion in Q3 2025 to a low of $16.6 billion in Q1 2021.
  • Average Current Assets over 5 years is $28.0 billion, with a median of $22.2 billion recorded in 2023.
  • Peak YoY movement for Current Assets: dropped 2.26% in 2022, then surged 97.58% in 2025.
  • A 5-year view of Current Assets shows it stood at $18.5 billion in 2021, then fell by 2.26% to $18.0 billion in 2022, then soared by 42.65% to $25.7 billion in 2023, then increased by 27.26% to $32.7 billion in 2024, then surged by 69.91% to $55.6 billion in 2025.
  • Per Business Quant, the three most recent readings for LLY's Current Assets are $55.6 billion (Q4 2025), $62.1 billion (Q3 2025), and $49.9 billion (Q2 2025).